Skip to main content
. 2022 May 10;12:7665. doi: 10.1038/s41598-022-11860-y

Figure 2.

Figure 2

The proportion of current smokers during IBD diagnosis and control selection, stratified by year. Patients were classified based on year at diagnosis (before 1990, 1991–1995, 1996–2000, 2001–2005, 2006–2010, 2011–2015, and 2016–2020). The crude prevalence of current smoking decreased from 32.5% (1990) to 13% (2018) in the control group (p < 0.01) and 25% (before 1990) to 7% (2016–2020) in UC patients (p = 0.04), whereas the prevalence of current smoking did not decrease over time and remained stable at approximately 9% in CD patients (p = 0.89).